Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study.
Van Assche IA, Van Calsteren K, Huis In 't Veld EA, van Gerwen M, Heylen L, LeJeune CL, Cardonick E, Halaska MJ, Fruscio R, Fumagalli M, van Dijk-Lokkart EM, Lemiere J, van Grotel M, Lagae L, van den Heuvel-Eibrink MM, Amant F. Van Assche IA, et al. Among authors: amant f. EClinicalMedicine. 2024 Nov 11;78:102922. doi: 10.1016/j.eclinm.2024.102922. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39588212 Free PMC article.
Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review.
Taliento C, Scutiero G, Battello G, Sala A, Pellecchia G, Trozzi R, Arcieri M, Pavone M, Bizzarri N, Greco P, Driul L, Amant F, Fagotti A, Scambia G, Vizzielli G, Restaino S. Taliento C, et al. Among authors: amant f. Eur J Surg Oncol. 2024 Nov 7;51(1):109359. doi: 10.1016/j.ejso.2024.109359. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39531915 Review.
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG. De Jaeghere EA, et al. Among authors: amant f. Gynecol Oncol. 2024 Nov 7;191:275-286. doi: 10.1016/j.ygyno.2024.10.020. Online ahead of print. Gynecol Oncol. 2024. PMID: 39515198
Germline copy number variants and endometrial cancer risk.
Stylianou CE, Wiggins GAR, Lau VL, Dennis J, Shelling AN, Wilson M, Sykes P, Amant F, Annibali D, De Wispelaere W, Easton DF, Fasching PA, Glubb DM, Goode EL, Lambrechts D, Pharoah PDP, Scott RJ, Tham E, Tomlinson I, Bolla MK, Couch FJ, Czene K, Dörk T, Dunning AM, Fletcher O, García-Closas M, Hoppe R; ABCTB Investigators; Jernström H, Kaaks R, Michailidou K, Obi N, Southey MC, Stone J, Wang Q, Spurdle AB, O'Mara TA, Pearson J, Walker LC. Stylianou CE, et al. Among authors: amant f. Hum Genet. 2024 Dec;143(12):1481-1498. doi: 10.1007/s00439-024-02707-9. Epub 2024 Nov 4. Hum Genet. 2024. PMID: 39495297 Free PMC article.
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.
Haggstrom L, Lee YC, Scott C, Harter P, Woelber L, Ledermann J, Gourley C, McNeish IA, Amant F, Ray-Coquard I, Leary A, Oza AM, Tinker A, González Martin A, Cecere SC, Pignata S, Colombo N, Yoshida H, Marth C, Rosengarten O, Moore KN, Gómez-García EM, Tan D, Friedlander ML. Haggstrom L, et al. Among authors: amant f. Int J Gynecol Cancer. 2024 Dec 2;34(12):1932-1939. doi: 10.1136/ijgc-2024-005976. Int J Gynecol Cancer. 2024. PMID: 39438068
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
Perrone E, Capasso I, Giannarelli D, Trozzi R, Congedo L, Ervas E, Tarantino V, Esposito G, Palmieri L, Guaita A, van Rompuy AS, Scaglione G, Zannoni GF, Scambia G, Amant F, Fanfani F. Perrone E, et al. Among authors: amant f. Gynecol Oncol. 2024 Oct 17;191:150-157. doi: 10.1016/j.ygyno.2024.10.010. Online ahead of print. Gynecol Oncol. 2024. PMID: 39423552
592 results